[breadcrumb_custom]

How To Know If TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) Is Expensive At $1.10.

In last trading session, TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) saw 1.05 million shares changing hands with its beta currently measuring 0.07. Company’s recent per share price level of $1.10 trading at $0.16 or 16.91% at ring of the bell on the day assigns it a market valuation of $0.75M. That closing price of TCBP’s stock is at a discount of -14027.27% from its 52-week high price of $155.40 and is indicating a premium of 22.73% from its 52-week low price of $0.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.04 million shares which gives us an average trading volume of 302.88K if we extend that period to 3-months.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) trade information

Upright in the green during last session for gaining 16.91%, in the last five days TCBP remained trading in the green while hitting it’s week-highest on Thursday, 02/08/24 when the stock touched $1.10 price level, adding 10.57% to its value on the day. TC BioPharm (Holdings) plc ADR’s shares saw a change of -65.30% in year-to-date performance and have moved 2.80% in past 5-day. TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP) showed a performance of -50.89% in past 30-days. Number of shares sold short was 53130.0 shares which calculate 0.23 days to cover the short interests.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

TCBP Dividends

TC BioPharm (Holdings) plc ADR is more likely to be releasing its next quarterly report in March and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.

TC BioPharm (Holdings) plc ADR (NASDAQ:TCBP)’s Major holders

Insiders are in possession of 0.14% of company’s total shares while institution are holding 0.29 percent of that, with stock having share float percentage of 0.29%. Investors also watch the number of corporate investors in a company very closely, which is 0.29% institutions for TC BioPharm (Holdings) plc ADR that are currently holding shares of the company. Armistice Capital, LLC is the top institutional holder at TCBP for having 0.53 million shares of worth $0.29 million. And as of Jun 29, 2023, it was holding 6.52% of the company’s outstanding shares.

The second largest institutional holder is Citadel Advisors Llc, which was holding about 75295.0 shares on Jun 29, 2023. The number of shares represents firm’s hold over 0.93% of outstanding shares, having a total worth of $40809.0.

On Key

Related Posts